共 41 条
- [21] First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy OpportunitiesJAMA NETWORK OPEN, 2023, 6 (07) : e2323336Matsubara, JunichiMukai, KumiKondo, TomohiroYoshioka, MasahiroKage, HidenoriOda, KatsutoshiKudo, RyoIkeda, SadakatsuEbi, HiromichiMuro, KeiHayashi, RyujiTokudome, NahomiYamamoto, NobuyukiMuto, Manabu
- [22] Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy optionsMolecular Medicine, 2020, 26Long HuangXiao-Liu JiangHong-Bin LiangJian-Cheng LiLi-Han ChinJian-Ping WeiRui-Ru WangJing CaiQiang XiongLien-Tu WangDavid S. CramAn-Wen Liu
- [23] Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy optionsMOLECULAR MEDICINE, 2020, 26 (01)Huang, LongJiang, Xiao-LiuLiang, Hong-BinLi, Jian-ChengChin, Li-HanWei, Jian-PingWang, Rui-RuCai, JingXiong, QiangWang, Lien-TuCram, David S.Liu, An-Wen
- [24] Correlation between findings from comprehensive genomic profiling and targeted therapy response in metastatic renal cell carcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)Thai Huu HoChoueiri, Toni K.Wang, KaiKaram, Jose A.Chalmers, Zachary RockowFrampton, Garrett MichaelElvin, Julia AndreaJohnson, AdrienneLiu, XueliLin, YulanJoseph, Richard WayneStanton, Melissa L.Miller, Vincent A.Stephens, Philip J.Ross, Jeffrey S.Ali, Siraj MahamedPal, Sumanta K.
- [25] Clinical utility of comprehensive genomic profiling and targeted therapy in biliary tract cancers: A real-world experience.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Shahid, MahumAbdallah, Mohamed A.Ellithi, MoatazAbdullah, Hafez MohammadNelson, MorganSolomon, Benjamin MauriceBleeker, Jonathan
- [26] Targeted Next-generation Sequencing of Solid Tumors versus Comprehensive Genomic Profiling Using Large Gene Panels: A Comparative StudyJOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1010 - 1010Routh, J.Gullapalli, R. R.Vasef, M.
- [27] COMPREHENSIVE GENOMIC PROFILING (CGP) OF PEDIATRIC GLIOMAS REVEALS A HIGH FREQUENCY OF CLINICALLY RELEVANT GENOMIC ALTERATIONS (CRGA) ASSOCIATED WITH BENEFIT FROM TARGETED THERAPYNEURO-ONCOLOGY, 2015, 17 : 7 - 8Chalmers, Zachary R.Ali, Siraj M.Frampton, Garrett M.Chmielecki, JuliannPalma, Norma A.Elvin, Julia A.Johnson, AdrienneYelensky, RomanRoss, Jeffery S.Stephens, Phillip J.Miller, Vincent A.Waanders, Angela J.Crawford, John
- [28] The utility of comprehensive genomic profiling in selection of actionable targeted therapy in recurrent or refractory epithelial ovarian, fallopian tube and peritoneal carcinomaGYNECOLOGIC ONCOLOGY, 2018, 149 : 183 - 183Achariyapota, V.Burke, W. M.Ruiz, M. P.Sia, T.Tergas, A. I.Clair, C. St.Wright, J. D.Hou, J. Y.
- [29] Comprehensive genomic profiling of urothelial carcinoma of the kidney and ureter: Comparison with urothelial carcinoma of the bladder and impact on potential for targeted therapy selectionJOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)Pal, Sumanta K.Elvin, Julia AndreaAli, Siraj MahamedHoffman-Censits, Jean H.Vergilio, Jo-AnneSuh, JamesMian, BadarFisher, Hugh A. G.Nazeer, TipuMiller, Vincent A.Stephens, Philip J.Ross, Jeffrey S.
- [30] Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapiesGYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 554 - 559Ross, J. S.Ali, S. M.Wang, K.Palmer, G.Yelensky, R.Lipson, D.Miller, V. A.Zajchowski, D.Shawver, L. K.Stephens, P. J.